Drugs / JNJ38224342
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01054352 | Feb 2010 → Mar 2011 | seasonal allergic rhinitis | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JNJ 38224342 | “A Single and Multiple Dose Study to Explore the Safety of JNJ-38224342 in Healthy Patients and Patients With Seasonal Allergies” NCT01054352 ↗ |
| Route | Oral | “multiple ascending oral doses (100, 250, 500, 750 mg) of JNJ 38224342 or matching placebo” NCT01054352 ↗ |